EXHIBIT 10.91

                         TRADEMARK LICENSE AGREEMENT


       THIS  TRADEMARK  LICENSE  AGREEMENT  ("Agreement"),  effective as of
  October  12,  1998  is  made by and between CARALOE, INC. ("Licensor"), a
  Texas  corporation, having its principal place of business at 2001 Walnut
  Hill  Lane,  Irving,  Texas  75038,  and One Family, Inc.,  ("Licensee"),
  having  its  principal place of business at 8160 Blakeland Drive, Unit A,
  Littleton, CO 80125.

                             W I T N E S S E T H:

       WHEREAS,  Licensor  and  One  Family,  Inc., ("OFI") have previously
  entered  into a Supply Agreement (the "Supply  Agreement") for  the  sale
  by   Licensor  and  purchase  by  OFI  of  bulk  Aloe  vera  mucilaginous
  polysaccharide  including one particular product (hereinafter referred to
  under  the product name of Manapol[R] or Manapol[R] Powder) to be used as
  one  of  the  ingredients  in  a drink or drinks manufactured by OFI also
  containing  other  ingredients  and  substances  (the  "OFI  Manufactured
  Products"):

       WHEREAS,   Carrington   Laboratories,   Inc.,  a  Texas  corporation
  ("Carrington"), is the owner of the Trademark Manapol[R] (the "Mark") and
  has  granted  to Licensor a license to use the Mark and to license others
  to use it on a non-exclusive basis;

       WHEREAS,  Licensee  is  desirous  of  obtaining  from  Licensor, and
  Licensor  is willing to grant to Licensee, a license to use the Trademark
  Manapol[R]  (the  "Mark")  in connection with the advertising and sale of
  the  OFI  Manufactured  Products  subject  to  the  terms, conditions and
  restrictions set forth herein; and

       WHEREAS, Licensor and Licensee are mutually desirous of insuring the
  consistent quality of all products sold in connection with the Mark;

       NOW,  THEREFORE, in consideration of premises, the mutual covenants,
  promises  and  agreement  set  forth  herein, and other good and valuable
  consideration,   the   receipt   and  sufficiency  of  which  are  hereby
  acknowledged, the parties hereby covenant, promise and agree as follows:

                                  Article 1

                                   LICENSE

       1.1  Terms  and  Conditions.  Licensor hereby grants to Licensee the
  non-transferable  right  and  non  exclusive  license to use the Mark and
  associated  product (Manapol[R] powder), in connection with the labeling,
  advertising  and  sale  of the OFI Manufactured Products manufactured and
  sold  by  OFI for Licensee during the term of this Agreement.  During the
  term  of  this  Agreement, Licensee shall have the non exclusive right to
  use  the Mark in connection with the OFI Manufactured Products containing
  Manapol[R]  powder in a drink or drinks that are intended for sale to the
  ultimate consumer in the U.S.
<PAGE>
       1.2  License Coterminous With Supply Agreement.  The license granted
  by  this Agreement shall run coterminously with the Supply Agreement, and
  any  actions  or  events  which  shall operate to extend or terminate the
  Supply  Agreement  shall automatically extend or terminate this Agreement
  simultaneously.

       1.3  Sublicenses.  Licensee shall not have the right without written
  permission from Licensor to grant sublicenses with respect to the license
  granted  herein; however, Licensee may engage a third party or parties to
  make  and  affix  labels  for the OFI Manufactured Products in compliance
  with  Articles  2,3,  and 4 hereof, and/or to distribute and sell the OFI
  Manufactured Products in compliance with the terms and conditions of this
  Agreement.    Licensee  shall  be  expressly  obligated  to  ensure  full
  compliance with all terms and conditions of this Agreement.

                                  Article 2

                       CERTAIN OBLIGATIONS OF LICENSEE

       2.1  Representations  by  Licensee.  Licensee shall not represent in
  any  manner  that it owns any right, title or interest in or to the Mark.
  Licensee acknowledges that its use of the Mark shall inure to the benefit
  of  Licensor and shall not create in Licensee's favor any right, title or
  interest in or to the Mark.

       2.2  Discontinuation  of  Use  of  Mark.    Upon  the  expiration or
  termination  of  this  Agreement, Licensee will cease and desist from all
  use  of  the  Mark  in  any  manner  and  will  not adopt or use, without
  Licensor's  prior  written consent, any word or mark which is confusingly
  or  deceptively similar to the Mark, except that Licensee may continue to
  use  the  Mark  under  the  terms  and  conditions  of  this Agreement in
  connection  with any remaining supplies of the Manapol[R] drink or drinks
  purchased by Licensee from OFI until such supplies are exhausted. 

       2.3  Standards.   All products on which the Mark is used by Licensee
  shall be of consistent quality and shall meet or exceed all standards set
  by  Licensor, in Licensor's sole discretion, from time to time.  Licensee
  shall  have  thirty  (30)  days from the receipt of written notice of any
  change in the standards to comply with any new requirements.

       2.4  Use  of  Trademark.   Licensee shall not use the Mark except as
  specifically  set  forth  herein.  Without limiting the generality of the
  preceding  sentence,  Licensee  shall not use the Mark in connection with
  the  sale  or advertising of any products other than the OFI Manufactured
  Products.


                                  Article 3

                           MANUFACTURING AND SALE 

       3.1  Combination With Other Products.  Licensee shall not combine or
  cause  to  be combined Manapol[R] powder with any product or substance in
  any  manner  which  would  violate  any laws, rules or regulations of any
  state, federal or other governmental body. 
<PAGE>
       3.2  Compliance  by  Third  Parties.   Licensee shall take all steps
  reasonably  necessary  to  ensure  that its distributors, if any, and any
  other  parties  to whom it sells any of the OFI Manufactured Products for
  resale  do  not  relabel,  repackage,  advertise, sell or attempt to sell
  Manapol[R]  powder  or  any  of the OFI Manufactured Products in a manner
  that would violate this Agreement if done by Licensee.

       3.3  Manapol[R]  Content.    The  amount  of Manapol[R] powder to be
  contained  in each of the OFI Manufactured Products shall be no less than
  fifteen  milligrams  (15mgs) per ounce.  The parties shall meet once each
  year  to  determine  and  agree  upon  the  Manapol[R] powder content for
  existing and proposed OFI Manufactured Products.

                                  Article 4

                            LABELS AND ADVERTISING<PAGE>
       4.1  Regulatory  Compliance  of  Labels and Advertising.  All labels
  and  advertising  relating  to  the  OFI Manufactured Products offered in
  connection  with  the Mark must strictly comply with all applicable laws,
  rules and regulations in the U.S. relating to product ingredients. 

       4.2  Mandatory  Requirements.    Licensee  shall  cause  all labels,
  packaging,   advertising   and   promotional  materials  used  by  it  in
  advertising,  marketing  and  selling  any  product manufactured by or on
  behalf  of  Licensee  that  contains Manapol[R] powder to contain (i) the
  Mark,  (ii)  a  statement  setting  forth the concentration of Manapol[R]
  powder contained in such product, and (iii) the following legend:

         Manapol[R] powder is a registered trademark of Caraloe, Inc.

       4.3  Claims  by  Licensee.    Licensee hereby agrees not to make, or
  permit  any  of its employees, agents or distributors to make, any claims
  of any properties or results relating to Manapol[R] or Manapol[R] powder,
  unless such claims comply with the applicable laws, rules and regulations
  of the U.S.


                                  Article 5

                                   ROYALTY

       5.1  Licensee  agrees  to pay to Licensor a royalty of fifteen cents
  ($0.15) per product.

       5.2  Licensee  shall  make  the  royalty  payment to Licensor within
  thirty  (30)  days of receipt of an invoice from OFI for products shipped
  to Licensee. 

       5.3  All  payments  hereunder are to be paid in U.S. currency at the
  address set forth at the beginning of this Agreement.

                                  Article 6

               NEGATION OF WARRANTIES, DISCLAIMER AND INDEMNITY

       6.1  Negation  of  Warranties, etc.  Nothing in this Agreement shall
  be construed or interpreted as:
<PAGE>
       (a)  a    warranty  or  representation  by  Licensor  that  any  OFI
  Manufactured Products made, used, sold or otherwise disposed of under the
  license  granted  in this Agreement is or will be free of infringement or
  the like of the rights of third parties; or

       (b)  an  obligation  by  Licensor  to  bring or prosecute actions or
  suits  against  third  parties  for  infringement  or  the  like  of  the
  Manapol[R] powder; or

       (c)  granting  by implication, estoppel or otherwise any licenses or
  rights other than those expressly granted hereunder.

       6.2  Disclaimer.    LICENSOR  MAKES  NO  REPRESENTATIONS, EXTENDS NO
  WARRANTIES  OF  ANY  KIND,  EITHER  EXPRESS OR IMPLIED, INCLUDING BUT NOT
  LIMITED  TO  WARRANTIES  OF  MERCHANTABILITY,  FITNESS  AND FITNESS FOR A
  PARTICULAR  PURPOSE,  AND  ASSUMES  NO  RESPONSIBILITIES  WHATSOEVER WITH
  RESPECT  TO  THE  USE,  SALE  OR  OTHER  DISPOSITION  BY  LICENSEE OR ITS
  CUSTOMERS,  VENDEES OR OTHER TRANSFEREES, WITH RESPECT TO THE MARK OR ANY
  PRODUCTS MADE OR SOLD BY LICENSEE.

       6.3  Liability  of  Licensee  for Products.  As between Licensor and
  Licensee,  Licensee  shall assume all financial and other obligations for
  the  OFI  Manufactured  Products  made  for  it and sold by it under this
  Agreement and Licensor shall not incur any liability or responsibility to
  Licensee  or  to  third parties arising out of or connected in any manner
  with  Licensee's products made or sold pursuant to this Agreement.  In no
  event  shall  Licensor  be  liable  for  lost  profits,  special damages,
  consequential  damages  or  contingent  liabilities  arising  out  of  or
  connected  in  any  manner  with  this  Agreement or the OFI Manufactured
  Products made for or sold by Licensee under this Agreement.

       6.4  Indemnity  of  Licensor.   Licensee agrees to defend, indemnify
  and  hold  Licensor,  its  officers,  directors,  employees  and  agents,
  harmless  against  all claims, liabilities, demands, damages, expenses or
  losses  arising  out  of  or  connected  with  any  use,  sale  or  other
  disposition  of  Licensee's or OFI s Manufactured Products by Licensee or
  by any other party.

       6.5  Trademark   Infringement.    Licensor  shall,  however,  defend
  Licensee  against  any  claims  of  trademark infringement resulting from
  Licensee s use of the trademark Manapol[R] in the U.S.

                                  Article 7

                             TERM AND TERMINATION

       7.1  Term.    Unless terminated earlier as provided for herein, this
  Agreement  shall  remain  in  full  force and effect for a three (3)-year
  period  ending  at  midnight  on October 12, 2006.  This Agreement may be
  extended  or  renewed  as  provided  in  Section 1.2, or otherwise by the
  written agreement of the parties.
<PAGE>
       7.2  Breach  of  Agreement.  Except as provided otherwise in Section
  7.3,  if  either  party breaches any material provision of this Agreement
  and  fails  to  cure  the breach within thirty (30) days after receipt of
  written  notice  from  the nonbreaching party specifying the breach, then
  the  nonbreaching  party may terminate this Agreement upon written notice
  to  the  breaching party, which right of termination shall be in addition
  to,  and  not  in lieu of, all other rights and remedies the nonbreaching
  party  may  have against the breaching party under this Agreement, at law
  or  in  equity.    Failure by Licensor to give notice of termination with
  respect  to any such failure shall not be deemed a waiver of its right at
  a  later  date  to  give  such  notice if such failure continues or again
  occurs,  or  if  another  failure  occurs.  A breach by either party of a
  material  provision  of  the Supply Agreement shall be deemed a breach by
  such party of a material provision of this Agreement.

       7.3  Immediate Termination.  Licensor may immediately terminate this
  Agreement,  upon  written  notice to Licensee, upon the occurrence of any
  one or more of the following events:  (i) Licensee breaches any provision
  of  Articles 2, 3, or 4; (ii) OFI fails to purchase and/or to pay for the
  Manapol[R]  powder that it is obligated to purchase and pay for under the
  Supply  Agreement  in  accordance  with the terms thereof; (iii) Licensee
  voluntarily  seeks  protection  under  any federal or state bankruptcy or
  insolvency  laws;  (iv) a petition for bankruptcy or the appointment of a
  receiver  is  filed  against  Licensee and is not dismissed within thirty
  (30)  days  thereafter; (v) Licensee makes any assignment for the benefit
  of its creditors; or (vi) Licensee ceases doing business.

       7.4  Survival  of  Provisions.    In  the   event   of  termination,
  cancellation  or  expiration  of  this Agreement for any reason, Sections
  2.2,  6.1,  6.2,  6.3,  6.4,  6.5  and  8.1  hereof  shall  survive  such
  termination,  cancellation  or  expiration  and  remain in full force and
  effect.

                                  Article 8

                                MISCELLANEOUS

       8.1  Equitable  Relief.    A breach or default by Licensee of any of
  the  provisions  of  Articles  2,  3 and 4 hereof shall cause Licensor to
  suffer  irreparable  harm and, in such event, Licensor shall be entitled,
  as  a matter of right, to a restraining order and other injunctive relief
  from  any  court  of  competent  jurisdiction,  restraining  any  further
  violation  thereof by Licensee, its officers, agents, servants, employees
  and  those  persons  in  active  concert or participation with them.  The
  right  to  a  restraining  order  or  other  injunctive  relief  shall be
  supplemental  to  any other right or remedy Licensor may have, including,
  without  limitation, the recovery of damages for the breach or default of
  any of the terms of this Agreement.

       8.2  Amendment.  This Agreement may be changed, modified, or amended
  only  by  an  instrument  in writing duly executed by each of the parties
  hereto.

       8.3  Entire  Agreement.    This  Agreement  constitutes the full and
  complete agreement of the parties hereto and supersedes any and all prior
  understandings,  whether  written  or  oral,  with respect to the subject
  matter hereof. 
<PAGE>
       8.4  No  Waiver.   The failure of either party to insist upon strict
  performance  of any obligation hereunder by the other party, irrespective
  of  the  length  of time for which such failure continues, shall not be a
  waiver  of  its  right  to  demand  strict  compliance in the future.  No
  consent  or  waiver,  express  or  implied,  by either party to or of any
  breach  or  default in the performance of any obligation hereunder by the
  other  party  shall  constitute  a  consent  or waiver to or of any other
  breach  or default in the performance of the same or any other obligation
  hereunder.

       8.5  Notices.      All  notices  required or permitted to be made or
  given  pursuant  to  this  Agreement  shall  be  in  writing and shall be
  considered  as  properly  given or made when personally delivered or when
  duly  deposited  in the mails, first class mail, postage prepaid, or when
  transmitted  by prepaid telegram, and addressed to the applicable address
  first  above written or to such other address as the addressee shall have
  theretofore specified in a written notice to the notifying party.

       8.6  Assignment.  This Agreement or any of the rights or obligations
  created  herein  may  be  assigned,  in  whole  or  in part, by Licensor.
  However,  this  Agreement  is  personal to Licensee, and Licensee may not
  assign  this  Agreement or any of its rights, duties or obligations under
  this  Agreement  to  any  third  party  without  Licensor's prior written
  consent,  and any attempted assignment by Licensee not in accordance with
  this Section 9.6 shall be void.

       8.7  Relationship  of  Parties.    Nothing contained herein shall be
  construed  to create or constitute any employment, agency, partnership or
  joint venture arrangement by and between the parties, and neither of them
  has  the  power or authority, express or implied, to obligate or bind the
  other in any manner whatsoever.

       8.8  Remedies  Cumulative.    Unless  otherwise  expressly  provided
  herein,  the rights and remedies hereunder are in addition to, and not in
  limitation  of,  any  other rights and remedies, at law or in equity, and
  the  exercise  or  one right or remedy will not be deemed a waiver of any
  other right or remedy.

       8.9  Successors and Assigns.  The provisions of this Agreement shall
  be  binding  upon  and  inure  to  the  benefit  of the parties and their
  respective  successors and assigns, provided, however, that the foregoing
  shall  not  be  deemed  to  expand or otherwise affect the limitations on
  assignment  and delegation set forth in Section 7.6 hereof, and except as
  otherwise  expressly  provided  in  this  Agreement,  no  other person or
  business  entity is intended to or shall have any right or interest under
  this Agreement.

       8.10 Governing  Law.    This  Agreement  shall  be  governed  by and
  interpreted,  construed  and  enforced in accordance with the laws of the
  State of Texas, excluding, however, any conflicts of law rules that would
  require the application of the laws of any other state or country.
<PAGE>
       8.11 Headings.    The  headings  used  in  this  Agreement  are  for
  convenience  of  reference  only  and shall not be used to interpret this
  Agreement.

       8.12 Counterparts.    This  Agreement  may  be  executed in multiple
  counterparts,  each of which shall be deemed an original and all of which
  will constitute but one and the same instrument.

       IN  WITNESS  WHEREOF,  the  parties have caused this Agreement to be
  executed  by  their  duly authorized representatives as of the date first
  above written.

                                CARALOE, INC.



                                By:  \s\ Bill Pine                         
                                   
                                Name:    Bill Pine
                                Title:   General Manager


                                ONE FAMILY, INC.



                                By:  \s\ Hilton Sher                       
                                 
                                Name:    Hilton Sher
                                Title:   Chief Financial Officer